ArticleChemical science2026
Deep docking, part 2: an amplified DDU platform for ultra-large virtual screening.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The exponential growth of accessible chemical space represents a significant computational challenge for structure-based virtual screening. Hence, active-learning and machine-learning approaches, such as Deep Docking, have been introduced to significantly speed up this process; yet even such methods became computationally prohibitive as docking libraries expanded into and beyond billion-entries levels. To address this challenge, we herein introduce the Deep Docking Ultra (DDU) approach, which integrates advanced acquisition functions with a pre-trained molecular large language model (MLLM). We demonstrate that such a combination improves accuracy of docking score emulations, while significantly reducing their computational costs. Through 384 virtual screening experiments involving 12 proteins from all major target classes, we systematically benchmarked DDU performance to identify optimal configurations that reduce required computations by up to 45-fold compared to the original Deep Docking method, and by up to 28 500-fold, compared to brute-force docking, without compromising predictive accuracy. We further demonstrate that DDU is able to screen 10.1 billion ligands against the phosphoglycerate kinase 2 target in just 10 days using 50 tesla V100 GPUs, and yields an overall docking enrichment factor of 12 000.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.